Dr. Jorg Taubel will be attending the AGAH Annual Meeting. As a pivotal event in the field of clinical pharmacology, the AGAH Annual Meeting brings together experts and professionals from around the world.

Since 1999, these gatherings have been a cornerstone of collaboration with esteemed international partner organisations, including the American College of Clinical Pharmacology (ACCP), the French Club Phase 1, the Belgian Association of Phase-1 Units (BAPU), and the British Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI).

Dr. Taubel's participation underscores our commitment to advancing knowledge and fostering collaboration in clinical pharmacology.

To find out more: https://www.agah.eu/events/annual-meetings/ 

Latest news

リッチモンド社、Beam Therapeuticsと共にα1アンチトリプシン欠乏症(AATD)の画期的な試験を実施

April 1, 2025
リッチモンドは、Beam Therapeutics が実施中の第1/2相試験において、α1アンチトリプシン欠乏症(AATD)の新たな治療法候補に関する最初の3つの用量レベルの予備的結果が得られたことを発表
Read more

リッチモンド、サステナビリティ・アクセラレータープログラムを通じてESGへの取り組みを強化  

March 31, 2025
私たちは、責任ある持続可能なビジネス成長を促進するために、環境・社会・ガバナンス(ESG)の原則を臨床研究業務に組み込むことに取り組んでいます。
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event